Lunit Overview
Pro stress-test →Lunit is a leading provider of AI for cancer diagnostics and precision oncology. The company develops AI-powered medical imaging analysis and biomarker discovery solutions that enable radiologists and oncologists to improve cancer detection, diagnosis, and patient stratification. Based in Seoul with operations in New York and Amsterdam, Lunit is commercializing its technology globally through partnerships with healthcare institutions and the broader medical device ecosystem.
Strategic Profile
Pro stress-test →Lunit is entering a full-scale monetization phase for its medical AI business developed in collaboration with Microsoft. The company developed a Foundation Model Service (FMS) that enables medical institutions to optimize Lunit's AI models for their hospital environments using their own data. In May 2026, Lunit signed MOUs with major Korean hospitals including National Health Insurance Service Ilsan Hospital and Severance Hospital to collaborate on AI transformation across hospital treatment, operations, and administration.
Competitive Landscape
Pro stress-test →Lunit's INSIGHT mammography AI demonstrated superior performance (81.9% sensitivity, 95.6% accuracy) compared to competitors Screenpoint and Zebra Medical Vision in published clinical studies. The company competes in the medical imaging AI diagnostics space with other AI radiology vendors and integrated medical device manufacturers, but differentiates through hospital-customized foundation models and strong clinical validation.
Industry Context
Lunit operates in Medical imaging AI diagnostics.
Key facts
Founded: 2014 · Headquarters: Seoul, South Korea · Revenue: $XX million